© 2020 MJH Life Sciences and OncLive. All rights reserved.
May 27th 2020, 3:46am
Lawrence D. Kaplan, MD, discusses research with bispecific monoclonal antibodies in follicular lymphoma.
May 22nd 2020, 1:39am
Hope S. Rugo, MD, discusses the results of the phase 3 KEYNOTE-522 trial in triple-negative breast cancer (TNBC).
May 19th 2020, 2:35am
Hope S. Rugo, MD, discusses recent updates with immunotherapy in triple negative breast cancer.
May 19th 2020, 12:55am
May 14th 2020, 5:46pm
Hope S. Rugo, MD, discusses the research that was born from the results of the IMpassion130 trial and the future of immunotherapy in triple-negative breast cancer.
May 14th 2020, 1:51pm
May 14th 2020, 2:19am
Hope S. Rugo, MD, discusses takeaways from the phase 3 IMpassion130 trial in metastatic triple-negative breast cancer.
May 13th 2020, 10:23pm
May 13th 2020, 6:06pm
Combining the PD-1 inhibitor pembrolizumab with intratumoral plasmid interkeukin-12 electroporation elicited clinical responses in patients with immunologically quiescent advanced melanoma.
May 13th 2020, 2:05pm